Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.3898
+0.0038 (0.98%)
At close: Dec 19, 2025, 4:00 PM EST
0.3935
+0.0037 (0.95%)
After-hours: Dec 19, 2025, 7:16 PM EST
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.55 million as of December 19, 2025. Its market cap has decreased by -66.24% in one year.
Market Cap
2.55M
Enterprise Value
-349.23K
1-Year Change
-66.24%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $2.55M, a decrease of -98.77%. That is a compound annual growth rate of -72.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 2.55M | -73.89% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |